BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 12362695)

  • 21. Age, hormone therapy use, coronary heart disease, and mortality.
    Allison MA; Manson JE
    Menopause; 2011 Mar; 18(3):243-5. PubMed ID: 21301373
    [No Abstract]   [Full Text] [Related]  

  • 22. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term trials of HRT for cardioprotection--is this as good as it gets?
    MacLennan AH; Sturdee DW
    Climacteric; 2007 Feb; 10(1):1-4. PubMed ID: 17364597
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 26. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines advise against hormone replacement therapy for cardiovascular disease prevention.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):7-9. PubMed ID: 12296365
    [No Abstract]   [Full Text] [Related]  

  • 28. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH; van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2127-30. PubMed ID: 12474550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arterial hypertension, menopause and hormone substitution].
    Gannage-Yared MH; Atallah C; Jambart S
    J Med Liban; 2000; 48(6):387-91. PubMed ID: 11503532
    [No Abstract]   [Full Text] [Related]  

  • 31. [Should hormone replacement therapy for menopause be continued in diabetic women?].
    Skurnik G; Touraine P
    Journ Annu Diabetol Hotel Dieu; 2004; ():151-60. PubMed ID: 15259313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statement on results of the HERS II trial on hormone replacement therapy.
    American College of Obstetricians and Gynecologists
    Ginecol Obstet Mex; 2002 Aug; 70():406-8. PubMed ID: 12448046
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with estrogen].
    Ingelman-Sundberg A
    Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
    Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The missing R.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2003 Apr; 17(2):91-4. PubMed ID: 12741416
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormone replacement therapy: the right choice for your patient?
    Leong SL; Erickson DR; Pees RC
    J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.